137 related articles for article (PubMed ID: 9290699)
41. An efficient and reliable multiplex PCR-SSCP mutation analysis test applied to the human E-cadherin gene.
Berx G; Nollet F; Strumane K; van Roy F
Hum Mutat; 1997; 9(6):567-74. PubMed ID: 9195232
[TBL] [Abstract][Full Text] [Related]
42. von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens.
Zhuang Z; Emmert-Buck MR; Roth MJ; Gnarra J; Linehan WM; Liotta LA; Lubensky IA
Hum Pathol; 1996 Feb; 27(2):152-6. PubMed ID: 8617456
[TBL] [Abstract][Full Text] [Related]
43. Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene.
Cybulski C; Krzystolik K; Maher ER; Richard S; Kurzawski G; Gronwald J; Lubiński J
Hum Genet; 1999 Oct; 105(4):333-6. PubMed ID: 10543401
[TBL] [Abstract][Full Text] [Related]
44. Detection and identification of Ki-ras exon 1 mutations by minigel single-strand conformation polymorphism.
Ulvik A; Aarskog NK; Ogreid D
Anal Biochem; 1995 Nov; 232(1):137-8. PubMed ID: 8600822
[No Abstract] [Full Text] [Related]
45. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman JG; Latif F; Weng Y; Lerman MI; Zbar B; Liu S; Samid D; Duan DS; Gnarra JR; Linehan WM
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9700-4. PubMed ID: 7937876
[TBL] [Abstract][Full Text] [Related]
46. Genomic changes of the 55 kDa subunit of DNA polymerase epsilon in human breast cancer.
Zhou Q; Effati R; Talvinen K; Pospiech H; Syväoja JE; Collan Y
Cancer Genomics Proteomics; 2008; 5(5):287-92. PubMed ID: 19129559
[TBL] [Abstract][Full Text] [Related]
47. Mutational state of von Hippel-Lindau and adenomatous polyposis coli genes in renal tumors.
Suzuki H; Ueda T; Komiya A; Okano T; Isaka S; Shimazaki J; Ito H
Oncology; 1997; 54(3):252-7. PubMed ID: 9143408
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of gene testing for von Hippel-Lindau disease.
Martin RL; Goldblatt J; Walpole IR
Med J Aust; 1998 Oct; 169(8):422-4. PubMed ID: 9830390
[TBL] [Abstract][Full Text] [Related]
49. Comparative genomic analysis of growth hormone gene in geese.
Zhao WM; Qiao N; Wang XB; Chen Q; Cheng JH; Xu Q; Chen GH
Anim Sci J; 2011 Feb; 82(1):62-6. PubMed ID: 21269361
[TBL] [Abstract][Full Text] [Related]
50. Detection of deletion 1154-1156 hypophosphatasia mutation using TNSALP exon amplification.
Orimo H; Goseki-Sone M; Sato S; Shimada T
Genomics; 1997 Jun; 42(2):364-6. PubMed ID: 9192863
[No Abstract] [Full Text] [Related]
51. Intragenic Tsc2 somatic mutations as Knudson's second hit in spontaneous and chemically induced renal carcinomas in the Eker rat model.
Kobayashi T; Urakami S; Hirayama Y; Yamamoto T; Nishizawa M; Takahara T; Kubo Y; Hino O
Jpn J Cancer Res; 1997 Mar; 88(3):254-61. PubMed ID: 9140109
[TBL] [Abstract][Full Text] [Related]
52. Genetic predisposition to transplacentally induced renal cell carcinomas in the Eker rat.
Hino O; Mitani H; Knudson AG
Cancer Res; 1993 Dec; 53(24):5856-8. PubMed ID: 8261394
[TBL] [Abstract][Full Text] [Related]
53. Genetic changes in the origin and development of renal cell carcinoma (RCC).
Glavac D; Ravnik-Glavac M; Ovcak Z; Masera A
Pflugers Arch; 1996; 431(6 Suppl 2):R193-4. PubMed ID: 8739330
[TBL] [Abstract][Full Text] [Related]
54. [The improvement of a direct DNA sequencing method by devising the primer design: detection of lipoprotein lipase gene aberrations].
Mori A; Takagi A; Ikeda Y; Yamamoto A
Rinsho Byori; 1996 Oct; 44(10):983-90. PubMed ID: 8937192
[TBL] [Abstract][Full Text] [Related]
55. BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors.
Marsden L; Jennings LJ; Gadd S; Yu M; Perlman EJ; Cajaiba MM
Hum Pathol; 2017 Feb; 60():32-36. PubMed ID: 27769870
[TBL] [Abstract][Full Text] [Related]
56. Genomic analysis of the 55 kDa subunit of DNA polymerase epsilon in human intracranial neoplasms.
Zhou Q; Lehtonen T; Lehtonen J; Laakso S; Szymas J; Pospiech H; Huoponen K; Syväoja J; Collan Y
Cancer Genomics Proteomics; 2010; 7(3):143-6. PubMed ID: 20551246
[TBL] [Abstract][Full Text] [Related]
57. Variant mutational activation of the K-ras oncogene in renal mesenchymal tumors induced in newborn F344 rats by methyl(methoxymethyl)nitrosamine.
Higinbotham KG; Rice JM; Reed CD; Watatani M; Enomoto T; Anderson LM; Perantoni AO
Carcinogenesis; 1996 Dec; 17(12):2625-30. PubMed ID: 9006098
[TBL] [Abstract][Full Text] [Related]
58. The von-Hippel-Lindau (VHL) tumor suppressor gene is not mutated in sporadic ovarian carcinomas.
Nakashima R; Enomoto T; Fujita M; Yoshino K; Wada H; Kondo K; Yao M; Murata Y
Oncol Rep; 1996 Sep; 3(5):887-90. PubMed ID: 21594475
[TBL] [Abstract][Full Text] [Related]
59. Mutation in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine.
Wang D; Weghorst CM; Calvert RJ; Stoner GD
Carcinogenesis; 1996 Apr; 17(4):625-30. PubMed ID: 8625469
[TBL] [Abstract][Full Text] [Related]
60. Connexin 37 mutations in rat hepatic angiosarcomas induced by vinyl chloride.
Saito T; Barbin A; Omori Y; Yamasaki H
Cancer Res; 1997 Feb; 57(3):375-7. PubMed ID: 9012458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
